Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Muiesan

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1997
Prognostic significance of left ventricular hypertrophy regressionE Agabiti-Rosei, M L Muiesan
Current Opinion in Nephrology and Hypertension|April 8, 1998
Cardiac hypertrophy and hypertensionE Agabiti-Rosei, M L Muiesan
Cardiologia (Rome, Italy)|December 1, 1986
[Medical therapy and regression of left ventricular hypertrophy in arterial hypertension]E Agabiti-Rosei, M L Muiesan, G Muiesan
Cardiologia (Rome, Italy)|December 25, 2002
[Selection criteria in the treatment of arterial hypertension and recommended guidelines]E Agabiti-Rosei, M L Muiesan, G Bettoni
Cardiologia (Rome, Italy)|December 1, 1988
[Treatment of arterial hypertension in elderly patients]G Muiesan, E Agabiti-Rosei, M L Muiesan
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1985
Adrenergic activity and myocardial anatomy and function in essential hypertensionG Muiesan, E Agabiti-Rosei, M L Muiesan
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 1, 1996
Cardiovascular structural alterations in hypertension: effect of treatmentE Agabiti-Rosei, M L Muiesan, D Rizzoni
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|October 1, 1993
[Antihypertensive treatment and left ventricular hypertrophy]E Agabiti-Rosei, M L Muiesan, D Rizzoni
American Journal of Hypertension|February 1, 1989
Regression of structural alterations in hypertensionE Agabiti-Rosei, M L Muiesan, G Muiesan
European Journal of Clinical Pharmacology|January 1, 1985
Effect of pinacidil on blood pressure, plasma catecholamines and plasma renin activity in essential hypertensionG Muiesan, R Fariello, M L Muiesan, et al.
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Advances in Experimental Medicine and Biology|January 1, 1997
Prognostic significance of left ventricular hypertrophy regressionE Agabiti-Rosei, M L Muiesan
Current Opinion in Nephrology and Hypertension|April 8, 1998
Cardiac hypertrophy and hypertensionE Agabiti-Rosei, M L Muiesan
Cardiologia (Rome, Italy)|December 1, 1986
[Medical therapy and regression of left ventricular hypertrophy in arterial hypertension]E Agabiti-Rosei, M L Muiesan, G Muiesan
Cardiologia (Rome, Italy)|December 25, 2002
[Selection criteria in the treatment of arterial hypertension and recommended guidelines]E Agabiti-Rosei, M L Muiesan, G Bettoni
Cardiologia (Rome, Italy)|December 1, 1988
[Treatment of arterial hypertension in elderly patients]G Muiesan, E Agabiti-Rosei, M L Muiesan
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1985
Adrenergic activity and myocardial anatomy and function in essential hypertensionG Muiesan, E Agabiti-Rosei, M L Muiesan
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 1, 1996
Cardiovascular structural alterations in hypertension: effect of treatmentE Agabiti-Rosei, M L Muiesan, D Rizzoni
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|October 1, 1993
[Antihypertensive treatment and left ventricular hypertrophy]E Agabiti-Rosei, M L Muiesan, D Rizzoni
American Journal of Hypertension|February 1, 1989
Regression of structural alterations in hypertensionE Agabiti-Rosei, M L Muiesan, G Muiesan
European Journal of Clinical Pharmacology|January 1, 1985
Effect of pinacidil on blood pressure, plasma catecholamines and plasma renin activity in essential hypertensionG Muiesan, R Fariello, M L Muiesan, et al.
Pageof 12